How many patents does
Metaproteomics have?
patents
209
families
33
granted
46
applications
163
US
57
EP
51
WO
14
CN
12
KR
7
JP
5
RoW
63
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Metaproteomics
Top ten assignees appearing on patents
2009 - 2018
| metaproteomics | 199 |
| metaprotemics | 3 |
| metaproteomics, llp. | 1 |
| metaproteonics | 1 |
2009
| metaproteomics | 32 |
| metaprotemics | 1 |
| metaproteomics, llp. | 1 |
2018
Metaproteomics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| modulation of inflammation by hops fractions and derivatives | 22 | 2001 |
| beta acid based protein kinase modulation cancer treatment | 16 | 2006 |
| curcuminoid compositions exhibiting synergistic inhibition of the expression and/or acti… 🛈 | 15 | 2001 |
| synergistic anti-inflammatory pharmaceutical compositions and related methods using curc… 🛈 | 14 | 2004 |
| substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-mono… 🛈 | 12 | 2008 |
| methods and compositions for heavy metal detoxification | 11 | 2007 |
| substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiog… 🛈 | 11 | 2007 |
| synergistic compositions that treat or inhibit pathological conditions associated with i… 🛈 | 10 | 2002 |
| methods and compositions for promoting bone and joint health | 9 | 2007 |
| anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatmen… 🛈 | 9 | 2003 |